Current Controlled Trials - Search the ISRCTN Register of Clinical Trials.

Welcome

12 February 2012

	Trial registration
	Unique identification scheme
	International databases

Find trials

ISRCTN Register

Registration

New application

Updating record

Information

introduction

governing board

ISRCTN FAQs

data set

guidance notes

International Standard Randomised Controlled Trial Number Register

Showing records: 5861 to 5870 of 10349

SEARCH FOR	RESULTS ORDER	DIRECTION	MAX RESULTS

5861	A Phase III randomised, double-blind, multicentre study to evaluate the safety and efficacy of 1592U89 (abacavir) in human immunodeficiency virus 1-infected patients with aquired immune deficiency syndrome dementia complex
	ISRCTN:	ISRCTN53707238
	Sponsor:	GlaxoSmithKline (UK)
	Date assigned:	19 June 2006

5862	Intermittent Preventive Therapy Post-Discharge: an innovative approach in the prevention of rebound severe malaria anaemia and mortality in young children
	ISRCTN:	ISRCTN89727873
	Sponsor:	Liverpool School of Tropical Medicine (UK)
	Date assigned:	19 June 2006

5863	Efficacy and safety of a two-step method of skin preparation for peripheral intravenous catheter insertion - a prospective multicentre randomised trial
	ISRCTN:	ISRCTN01075518
	Sponsor:	West Scientific Coordination Center for the Fight against Nosocomial Infections (CCLIN) (France)
	Date assigned:	19 June 2006

5864	A double-blind, randomised, crossover study to investigate the difference in frequency of episodes of hypoglycaemia during treatment with Biphasic Insulin Aspart 30 (NovoMix®30) compared to Biphasic Human Insulin 30 (Mixtard® 30) in patients with well-controlled, type 2 diabetes
	ISRCTN:	ISRCTN34091554
	Sponsor:	Novo Nordisk Ltd (UK)
	Date assigned:	19 June 2006

5865	A randomised, double-blind comparison of the microbiological, immunological and clinical effects of a high fructooligosaccharide diet compared with standard diet in patients with moderately active Crohn's disease
	ISRCTN:	ISRCTN50422530
	Sponsor:	Barts and the London NHS Trust
	Date assigned:	16 June 2006

5866	Pulmonary Hypertension: Assessment of Cell Therapy
	ISRCTN:	ISRCTN14519481
	Sponsor:	Northern Therapeutics Inc (Canada)
	Date assigned:	16 June 2006

5867	Lapatinib Pre-surgical Phase II Study in Patients with Primary Breast Cancer
	ISRCTN:	ISRCTN71165034
	Sponsor:	Imperial College London (UK)
	Date assigned:	16 June 2006

5868	An educational intervention to improve adverse drug reactions reporting: a cluster-randomised trial among Portuguese physicians and pharmacists
	ISRCTN:	ISRCTN45894687
	Sponsor:	Educational Development Program for Portugal (Programa de Desenvolvimento Educativo para Portugal) (PRODEP) (Portugal)
	Date assigned:	15 June 2006

5869	A comparative study of the efficacy of combination therapy with oral omeprazole and low dose of systemic meglumine antimoniate versus the standard dose of systemic meglumine antimoniate in the treatment of cutaneous leishmaniasis
	ISRCTN:	ISRCTN32701387
	Sponsor:	Skin Diseases and Leishmaniasis Research Center (SDLRC) (Iran)
	Date assigned:	15 June 2006

5870	Clinical investigation into efficacy, haemodynamics and tolerability of simvastatin versus placebo in patients with pulmonary arterial hypertension
	ISRCTN:	ISRCTN27178415
	Sponsor:	University Hospital Giessen (Germany)
	Date assigned:	14 June 2006

RESULT PAGE

587


© 2012 ISRCTN unless otherwise stated.